Characterization of the TCR repertoire in LTR revealed a higher involvement of the CD8+ T cells compared to CD4+ T cells, which is consistent with immunological studies in myeloma patients achieving long-term disease control showing increased frequencies of CD8+ T cells (31). Here, CD8A is linked to plasma cell myeloma.